• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AMS INFLATABLE PENILE PROSTHESIS WITH INHIBIZONE; DEVICE IMPOTENCE MECHANICAL/HYDRAULIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AMS INFLATABLE PENILE PROSTHESIS WITH INHIBIZONE; DEVICE IMPOTENCE MECHANICAL/HYDRAULIC Back to Search Results
Model Number 720185-01
Device Problem Insufficient Information (3190)
Patient Problems Cellulitis (1768); Fever (1858); Fistula (1862); Hemorrhage/Bleeding (1888); Inflammation (1932); Pain (1994); Perforation (2001); Urinary Tract Infection (2120); Fluid Discharge (2686)
Event Date 09/15/2019
Event Type  Injury  
Event Description
It was reported that the patient underwent an inflatable penile prosthesis (ipp) implant procedure and within fifteen days of discharge, the patient developed bleeding, redness, pain and fever.The patient was readmitted and found to have an urinary tract infection with scrotal wound drainage.A treatment of intra venous, and oral antibiotics was started after discharge.A month later, the patient underwent a removal procedure in which the existing pump was removed and replaced with a new one.During the procedure a small hole was found in the skin lying over the pump and a small fistula was also noted.The patient was discharged the same day and it is unclear if the ipp pump contributed to the event.It was also unclear if any device defect was identified.Additional information received.The infection was located in the patient's scrotum.The pump was moved to the opposite side.
 
Manufacturer Narrative
B5, h2, h6, h10 updated.
 
Event Description
It was reported that the patient underwent an inflatable penile prosthesis (ipp) implant procedure and within fifteen days of discharge, the patient developed bleeding, redness, pain and fever.The patient was readmitted and found to have an urinary tract infection with scrotal wound drainage.A treatment of intra venous, and oral antibiotics was started after discharge.A month later, the patient underwent a removal procedure in which the existing pump was removed and replaced with a new one.During the procedure a small hole was found in the skin lying over the pump and a small fistula was also noted.The patient was discharged the same day and it is unclear if the ipp pump contributed to the event.It was also unclear if any device defect was identified.Additional information received.The infection was located in the patient's scrotum.The pump was moved to the opposite side.Additional information received indicated that the patient experienced cellulitis within fifteen days of implant procedure.The drainage was not purulent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMS INFLATABLE PENILE PROSTHESIS WITH INHIBIZONE
Type of Device
DEVICE IMPOTENCE MECHANICAL/HYDRAULIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
10700 bren road w
minnetonka MN 55343
MDR Report Key9528571
MDR Text Key174461009
Report Number2183959-2019-68356
Device Sequence Number1
Product Code FHW
UDI-Device Identifier00878953005669
UDI-Public00878953005669
Combination Product (y/n)N
PMA/PMN Number
N970012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 03/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/26/2021
Device Model Number720185-01
Device Catalogue Number720185-01
Device Lot Number1000320682
Was Device Available for Evaluation? No
Date Manufacturer Received02/24/2020
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age68 YR
Patient Weight78
-
-